6/17
10:09 am
agio
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Low
Report
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
6/17
09:30 am
agio
Rating for AGIO
Medium
Report
Rating for AGIO
6/13
06:10 pm
agio
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "neutral" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $46.00 price target on the stock.
Medium
Report
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "neutral" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $46.00 price target on the stock.
6/13
05:06 pm
agio
Rating for AGIO
Medium
Report
Rating for AGIO
6/4
11:14 am
agio
Rating for AGIO
Medium
Report
Rating for AGIO
6/4
11:14 am
agio
Rating for AGIO
Medium
Report
Rating for AGIO
6/4
11:14 am
agio
Rating for AGIO
Medium
Report
Rating for AGIO
6/4
09:30 am
agio
Rating for AGIO
Medium
Report
Rating for AGIO
6/4
09:30 am
agio
Rating for AGIO
Medium
Report
Rating for AGIO
5/3
11:49 am
agio
Rating for AGIO
Low
Report
Rating for AGIO
5/3
11:49 am
agio
Rating for AGIO
Low
Report
Rating for AGIO
5/3
11:49 am
agio
Rating for AGIO
Low
Report
Rating for AGIO